Provided by Tiger Trade Technology Pte. Ltd.

BIOARCTIC AB

29.40
0.0000
Volume:- -
Turnover:- -
Market Cap:2.61B
PE:-227.13
High:29.40
Open:29.40
Low:29.40
Close:29.40
52wk High:40.00
52wk Low:27.82
Shares:88.64M
Float Shares:88.64M
Volume Ratio:1.46
T/O Rate:- -
Dividend:0.20
Dividend Rate:0.68%
EPS(TTM):-0.1294
EPS(LYR):0.2584
ROE:5.21%
ROA:4.78%
PB:12.84
PE(LYR):113.79

Loading ...

BioArctic Partner Eisai Wins China Approval for At-Home Leqembi Alzheimer’s Autoinjector

TIPRANKS
·
Sep 03

BioArctic’s Leqembi Wins Key Canadian Reimbursement Backing

TIPRANKS
·
Sep 01

BioArctic Updates Share and Vote Structure After Stock Option Exercise

TIPRANKS
·
Sep 01

BioArctic Deepens Alzheimer’s Footprint With Leqembi Expansion and New Strategic Alliances

TIPRANKS
·
Aug 26

Sweden's BioArctic Q2 Revenue Falls Despite Higher Leqembi Royalties

Reuters
·
Aug 26

BioArctic Q2 FY26 Turns to Net Loss of SEK 11.2 Million; Revenue Falls to SEK 247.5 Million

Reuters
·
Aug 26

BioArctic and Mesenkia team up on novel glioblastoma therapy

TIPRANKS
·
Aug 19

Subcutaneous Leqembi Autoinjector Matches IV Exposure, Promises More Flexible Alzheimer’s Care

TIPRANKS
·
Jul 13

Eli Lilly, BioArctic enter research pact for BrainTransporter combination

TIPRANKS
·
Jun 22

Eli Lilly, BioArctic Sign Neurodegeneration Research Deal Worth Up to $800 Million

MT Newswires Live
·
Jun 22

BioArctic's Fourth BrainTransporter Deal Signals Growing Platform Value -- Market Talk

Dow Jones
·
Jun 22

BioArctic AGM Backs Dividend, New Share Mandate and Employee Incentive Plan

TIPRANKS
·
May 29

Eisai Sees Strong 2028 Sales Potential for BioArctic’s Alzheimer’s Drug Leqembi

TIPRANKS
·
May 25

BioArctic lifts royalties and milestones as Leqembi expands globally amid mixed regulatory signals

TIPRANKS
·
May 20

BioArctic Showcases Leqembi Momentum and BrainTransporter Deals in 2025 Report

TIPRANKS
·
Apr 22

BioArctic Nomination Committee Proposes Strengthened Board Ahead of 2026 AGM

TIPRANKS
·
Mar 27